Fabry Disease With Aortic Regurgitation

Annals of Thoracic Surgery

Volumn 87, Issue 2, 2009, Pages 625-628

  Choi, Soojeong ^a   Seo, Haesun ^a   Park, Mooyong ^a   Kim, Jinkuk ^a   Hwang, Seungduk ^a   Kwon, Kaewon ^a   Her, Kyun ^a   Won, Yongsoon ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGALSIDASE BETA; ALPHA GALACTOSIDASE; LOSARTAN;

ADULT; AORTA VALVE REGURGITATION; ARTICLE; CASE REPORT; CELL VACUOLE; CLINICAL FEATURE; DYSPNEA; ECHOGRAPHY; FABRY DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ADULT; ALPHA-GALACTOSIDASE; AORTIC VALVE INSUFFICIENCY; BIOPROSTHESIS; BIOPSY, NEEDLE; FABRY DISEASE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 58249136624     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.06.023     Document Type: Article

References (8)

1. Desnick R.J., Brady R., Barranger J., et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138 (2003) 338-346
2. Linhart A., Paleček T., Bultas J., et al. New insight in cardiac structural changes in patients with Fabry's disease. Am Heart J 139 (2000) 1101-1108
3. Kampmann C., Baehner F., Whybra C., et al. Cardiac manifestations of Anderson-Fabry Disease in Heterozygous Females. J Am Coll Cardiol 40 (2002) 1668-1674
4. Eng C.M., Guffon N., Wilcox W.R., et al. Safety and efficiency of recombinant human alfa-galactosidase: a replacement therapy in Fabry's disease. N Engl J Med 345 (2001) 9-16
5. Weidemann F., Breunig F., Beer M., et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 108 (2003) 1299-1301
6. Iwase M., Yamauchi K., Aoki T., et al. Echocardiographic findings in a case of Fabry's disease with aortic regurgitation and complete AV block, and in his family members. J Cardiol 18 (1988) 589-598
7. Owen C.L., Russel S., and Halushka M.K. Histologic and electron microscopy findings in myocardium of treated Fabry disease. Hum Pathol 37 (2006) 764-768
8. Wilcox W.R., Banikazemi M., Guffon N., et al. Long-term safety and deficiency of enzyme replacement therapy for Fabry disease. Am J Hum Genet 75 (2004) 65-74